Axsome Therapeutics Reports Data from MOMENTUM Phase 3 Trial with AXS-07 Demonstrated 'Significantly Faster Time To Pain Relief As Compared To Rizatriptan And Significantly Less Relapse Of Migraine Pain As Compared To Rizatriptan'